Cargando…
Single- and multiple-dose pharmacokinetics of inhaled indacaterol in healthy Chinese volunteers
Indacaterol is an inhaled, ultra–long-acting β(2)-agonist that provides 24-h bronchodilation with once-daily dosing in patients with chronic obstructive pulmonary disorder. This study evaluated the pharmacokinetics, safety, and tolerability of multiple daily inhaled doses of indacaterol 150 or 300 μ...
Autores principales: | Jiang, Ji, Li, Lilly, Yin, Hequn, Woessner, Ralph, Emotte, Corinne, Li, Ruobing, Khindri, Sanjeev, Pei, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426132/ https://www.ncbi.nlm.nih.gov/pubmed/24705947 http://dx.doi.org/10.1007/s13318-014-0197-6 |
Ejemplares similares
-
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
por: Khindri, Sanjeev, et al.
Publicado: (2011) -
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects
por: Inoue, Satoru, et al.
Publicado: (2021) -
Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients
por: Miller, David, et al.
Publicado: (2020) -
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2016) -
Single-dose and multiple-dose pharmacokinetics of zaltoprofen after oral administration in healthy Chinese volunteers
por: Li, Lingjun, et al.
Publicado: (2011)